Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system

buir.contributor.authorUyar, Tamer
buir.contributor.authorDurgun, Engin
buir.contributor.orcidUyar, Tamer|0000-0002-3989-4481
dc.citation.epage338en_US
dc.citation.spage331en_US
dc.citation.volumeNumber128en_US
dc.contributor.authorAytac, Z.en_US
dc.contributor.authorSen, H. S.en_US
dc.contributor.authorDurgun, Enginen_US
dc.contributor.authorUyar, Tameren_US
dc.date.accessioned2015-07-28T12:03:24Z
dc.date.available2015-07-28T12:03:24Z
dc.date.issued2015-04-01en_US
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.departmentNanotechnology Research Center (NANOTAM)en_US
dc.description.abstractHerein, hydroxypropyl-beta-cyclodextrin (HPCD) inclusion complex (IC) of a hydrophobic drug, sul- fisoxazole (SFS) was incorporated in hydroxypropyl cellulose (HPC) nanofibers (HPC/SFS/HPCD-IC-NF) via electrospinning. SFS/HPCD-IC was characterized by DSC to investigate the formation of inclusion complex and the stoichiometry of the complex was determined by Job’s plot. Modeling studies were also performed on SFS/HPCD-IC using ab initio technique. SEM images depicted the defect free uniform fibers and confirmed the incorporation of SFS/HPCD-IC in nanofibers did not alter the fiber morphology. XRD analyses showed amorphous distribution of SFS/HPCD-IC in the fiber mat. Release studies were performed in phosphate buffered saline (PBS). The results suggest higher amount of SFS released from HPC/SFS/HPCD-IC-NF when compared to free SFS containing HPC nanofibers (HPC/SFS-NF). This was attributed to the increased solubility of SFS by inclusion complexation. Sandwich configurations were prepared by placing HPC/SFS/HPCD-IC-NF between electrospun PCL nanofibrous mat (PCL-HPC/SFS/HPCD-IC-NF). Consequently, PCL-HPC/SFS/HPCD-IC-NF exhibited slower release of SFS as compared with HPC/SFS/HPCD-IC-NF. This study may provide more efficient future strategies for developing delivery systems of hydrophobic drugs.en_US
dc.description.provenanceMade available in DSpace on 2015-07-28T12:03:24Z (GMT). No. of bitstreams: 1 11539.pdf: 2089843 bytes, checksum: 99e1672602c148ccd86b3355ab6ba9c9 (MD5)en_US
dc.identifier.doi10.1016/j.colsurfb.2015.02.019en_US
dc.identifier.issn0927-7765
dc.identifier.urihttp://hdl.handle.net/11693/12845
dc.language.isoEnglishen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.colsurfb.2015.02.019en_US
dc.source.titleColloids and Surfaces B: Biointerfacesen_US
dc.subjectElectrospinningen_US
dc.subjectNanofibersen_US
dc.subjectHydroxypropyl celluloseen_US
dc.subjectCyclodextrinen_US
dc.subjectSulfisoxazoleen_US
dc.subjectMolecular modelingen_US
dc.titleSulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery systemen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sulfisoxazole:cyclodextrin_inclusion_complex_incorporated_in_electrospun_hydroxypropyl_cellulose_nanofibers_as_drug_delivery_system.pdf
Size:
1.99 MB
Format:
Adobe Portable Document Format
Description:
Full printable version